Importance Patients with specific cancers may be at higher risk than those without cancer for
coronavirus disease 2019 (COVID-19) and its severe outcomes. At present, limited data are …

Background Emerging data suggest variability in susceptibility and outcome to coronavirus
disease 2019 (COVID-19) infection. Identifying risk factors associated with infection and …

Cancer patients are a vulnerable population postulated to be at higher risk for severe
coronavirus disease 2019 (COVID-19) infection. Increased COVID-19 morbidity and …

Importance Non-Hispanic Black individuals experience a higher burden of COVID-19 than
the general population; hence, there is an urgent need to characterize the unique clinical …

Patients with cancer, both active and previously treated, may be at higher risk of severe
outcomes from COVID-19 compared to the general population (Dai et al., 2020; Bakouny et …

Abstract Coronavirus disease 2019 (COVID-19) is a novel infectious disease that has
spread worldwide. In the United States, COVID-19 disproportionately affects racial and …

(SARS-CoV-2), which causes the disease coronavirus 2019 (COVID-19), has ravaged the
United States since the first case was documented in Washington State in January 2020. By …

Background Data on patients with COVID-19 who have cancer are lacking. Here we
characterise the outcomes of a cohort of patients with cancer and COVID-19 and identify …

Individuals with cancer may be at high risk for coronavirus disease 2019 (COVID‐19) and
adverse outcomes. However, evidence from large population‐based studies examining …

PURPOSE Variation in risk of adverse clinical outcomes in patients with cancer and COVID-
19 has been reported from relatively small cohorts. The NCATS'National COVID Cohort …